Sales and Marketing

Showing 15 posts of 11520 posts found.

Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations

January 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …
xarelto_10_tablet1

Bayer and J&J successfully reverse $28 million Xarelto court payout

January 10, 2018 Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …
shire_image_4

Shire announces split into two business units, downgrades revenue forecast

January 9, 2018 Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease

Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
cindy_elkins_2x

Ex-Genentech exec named as new Juno Therapeutics CIO

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics

Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
handshake2

Sanofi and Alynylam rejig sees global rights switch-up

January 8, 2018 Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical

The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
shutterstock_158366573

The PROs and cons of pushing patient centricity

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
amgen_flag

FDA clears Amgen’s bone drug for multiple myeloma

January 8, 2018 Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma

Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
celgene_exteriors-3

Celgene in $7bn shot on Impact

January 8, 2018 Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical

Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
ablynx_flags-web

Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no

January 8, 2018 Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma

It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …

Pfizer exits neuroscience R&D space

January 8, 2018 Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …
spmsdsite

Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds

January 5, 2018 Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
davidepsteinheadshot_

Novartis Pharma Ex-CEO takes three roles in two days

January 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical

Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten

Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …

Takeda agrees $630m takeover of TiGenix

January 5, 2018 Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical

Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …
syneos_health_rgb_tm

INC Research and inVentiv merge to form Syneos Health

January 4, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Syneos Health, inVentiv Health

With the advent of the new year, INC Research and inVentiv Health have announced they are to merge operations under …
The Gateway to Local Adoption Series

Latest content